학술논문
Intravenous abciximab as a rescue therapy for immediate reocclusion after successful mechanical thrombectomy in acute ischemic stroke patients
Document Type
article
Author
François Delvoye; Stephane Loyau; Julien Labreuche; Guillaume Taylor; Benjamin Maier; Michel Piotin; Raphael Blanc; Simon Escalard; Lucas Di Meglio; Malek Ben Maacha; Hocine Redjem; Stanislas Smajda; Gabriele Ciccio; Solène Hébert; Candice Sabben; Martine Jandrot-Perrus; Alain Maertens De Noordhout; Mikael Mazighi; Benoit Ho-Tin-Noé; Jean-Philippe Desilles
Source
Platelets, Vol 33, Iss 2, Pp 285-290 (2022)
Subject
Language
English
ISSN
0953-7104
1369-1635
09537104
1369-1635
09537104
Abstract
Immediate reocclusion after mechanical thrombectomy (MT) for acute ischemic stroke (AIS) is a rare but devastating condition associated with poor functional outcome. The aim of this study was to gain insights into the mechanisms underlying immediate reocclusion, and to evaluate the efficacy and safety of the glycoprotein IIb/IIIa antagonist abciximab, for its treatment. Clinical data were collected from April 2015 to April 2019 in a monocentric prospective registry of AIS patients treated by MT. All patients with immediate reocclusion were retrospectively selected and subdivided into 2 groups according to abciximab treatment status. In vitro, the separate and combined effects of abciximab and alteplase on clot formation in whole blood under flow conditions were further investigated in microfluidic chambers. From 929 MT-treated patients, 21 had post-MT immediate reocclusion. Abciximab treatment in reocclusion patients (n = 10) led to higher rate of final recanalization (p